Literature DB >> 25182419

Hepatotoxic effects of (tri)azole fungicides in a broad dose range.

T Heise1, F Schmidt1, C Knebel1, S Rieke1, W Haider2, R Pfeil1, C Kneuer1, L Niemann1, P Marx-Stoelting3.   

Abstract

The toxicological relevance of effects observed at molecular stage, which occur at dose levels well below classical no-observed adverse effect levels is currently subject to controversial scientific debate. While the importance of molecular effects for the identification of a mode of action or an adverse outcome pathway is undisputed, their impact for other regulatory purposes remains uncertain. Here, we report the results of a 28-day rat-feeding study including three widely used hepatotoxic (tri)azole fungicides (cyproconazole, epoxiconazole and prochloraz) administered individually at five dose levels, ranging from slightly above the reference values to a clear toxic effect dose. Parameters analysed included pathology, histopathology, clinical chemistry and particularly effects on the molecular level. Since azole fungicides are considered to cause liver toxicity by a mechanism involving the constitutive androstane receptor (CAR), a known CAR activator (phenobarbital, PB) was administered to investigate potential similarities between triazoles and PB-mediated liver toxicity by pathway-focused gene expression analysis. Our results show an increase in liver weights and additionally histopathological changes (hepatocellular hypertrophy) for all substances at the top dose levels. The effects on liver weight were most pronounced for cyproconazole by which also the animals receiving the next lower dose were affected. In addition, vacuolisation of hepatocytes was observed at the top dose level. No such findings were obtained with any substance at lower doses to which consumers and operators might be exposed to. In contrast, the expression of sensitive marker genes (like some cytochrome-P-450 isoforms) was significantly affected also at the lower dose levels. While some of these changes, like the induction of genes related to fatty acid and phospholipid metabolism (e.g. Fasn, Fat/Cd36, Ppargc1a) or xenobiotic metabolism (Cyp1a1, Cyp2b1, Cyp3a2), could be associated with high dose effects like hepatocellular vacuolisation or hypertrophy, a histopathological correlate was lacking for others.

Entities:  

Keywords:  Adverse outcome pathway; Liver; Low dose; Phenobarbital; Triazole

Mesh:

Substances:

Year:  2014        PMID: 25182419     DOI: 10.1007/s00204-014-1336-1

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  11 in total

1.  Safety assessment of the dietary supplement OxyELITE™ Pro (New Formula) in inbred and outbred mouse strains.

Authors:  Isabelle R Miousse; Charles M Skinner; Haixia Lin; Laura E Ewing; Stanley D Kosanke; D Keith Williams; Bharathi Avula; Ikhlas A Khan; Mahmoud A ElSohly; Bill J Gurley; Igor Koturbash
Journal:  Food Chem Toxicol       Date:  2017-08-24       Impact factor: 6.023

2.  Oxidative stress, genotoxicity, biochemical and histopathological modifications induced by epoxiconazole in liver and kidney of Wistar rats.

Authors:  Hiba Hamdi; Yosra Ben Othmène; Oumaima Ammar; Aida Klifi; Elhem Hallara; Faten Ben Ghali; Zohra Houas; Mohamec Fadhel Najjar; Salwa Abid-Essefi
Journal:  Environ Sci Pollut Res Int       Date:  2019-04-25       Impact factor: 4.223

3.  The Use of the Nematode Caenorhabditis elegans to Evaluate the Adverse Effects of Epoxiconazole Exposure on Spermatogenesis.

Authors:  Yunhui Li; Minhui Zhang; Shaojun Li; Rongrong Lv; Pan Chen; Ran Liu; Geyu Liang; Lihong Yin
Journal:  Int J Environ Res Public Health       Date:  2016-10-08       Impact factor: 3.390

4.  Hepatotoxic combination effects of three azole fungicides in a broad dose range.

Authors:  T Heise; F Schmidt; C Knebel; S Rieke; W Haider; I Geburek; L Niemann; P Marx-Stoelting
Journal:  Arch Toxicol       Date:  2017-10-16       Impact factor: 5.153

Review 5.  The Connection of Azole Fungicides with Xeno-Sensing Nuclear Receptors, Drug Metabolism and Hepatotoxicity.

Authors:  Philip Marx-Stoelting; Constanze Knebel; Albert Braeuning
Journal:  Cells       Date:  2020-05-11       Impact factor: 6.600

Review 6.  Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR.

Authors:  Jenni Küblbeck; Jonna Niskanen; Paavo Honkakoski
Journal:  Cells       Date:  2020-10-15       Impact factor: 6.600

7.  Induction and repression effects on CYP and transporter protein abundance by azole mixture uptake in rat liver.

Authors:  Helen Hammer; Flavia Schmidt; Tanja Heise; Constanze Knebel; Alexander Dabrowski; Hannes Planatscher; Carsten Kneuer; Philip Marx-Stoelting; Oliver Pötz
Journal:  EXCLI J       Date:  2020-06-26       Impact factor: 4.068

8.  An approach for mixture testing and prioritization based on common kinetic groups.

Authors:  Albert Braeuning; Denise Bloch; Mawien Karaca; Carsten Kneuer; Stefanie Rotter; Tewes Tralau; Philip Marx-Stoelting
Journal:  Arch Toxicol       Date:  2022-03-19       Impact factor: 6.168

9.  RNA-protein correlation of liver toxicity markers in HepaRG cells.

Authors:  Albert Braeuning; Almut Mentz; Felix F Schmidt; Stefan P Albaum; Hannes Planatscher; Jörn Kalinowski; Thomas O Joos; Oliver Poetz; Dajana Lichtenstein
Journal:  EXCLI J       Date:  2020-01-17       Impact factor: 4.068

10.  Cross-species analysis of hepatic cytochrome P450 and transport protein expression.

Authors:  Helen Hammer; Felix Schmidt; Philip Marx-Stoelting; Oliver Pötz; Albert Braeuning
Journal:  Arch Toxicol       Date:  2020-11-04       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.